| India | Thailand | Turkey | |
| Radiation therapy for colorectal cancer | from AUD $4,623 | from AUD $7,946 | from AUD $10,113 |
| Radiation therapy for esophageal carcinoma | from AUD $5,490 | from AUD $11,557 | from AUD $10,113 |
| Esophagectomy | from AUD $11,268 | from AUD $28,893 | from AUD $33,805 |
| Chemotherapy for esophageal carcinoma | from AUD $1,589 | from AUD $10,113 | from AUD $7,223 |
| Chemotherapy for breast cancer | from AUD $5,056 | from AUD $4,334 | from AUD $1,734 |
No hidden fees – just official clinic prices. Pay at the clinic for Esophageal cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Esophageal cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Esophageal cancer treatment journey.
Dr Nagender Sharma leads medical oncology at Medanta Hospital, focusing on personalised drug therapies for gastrointestinal and ठोस organ tumours.
Dr Shruti Kate was a consultant at the world-renowned Tata Memorial Hospital, where she trained in managing complex solid tumours like oesophageal cancer.
Dr Lalit Banswal has performed over 10,000 major surgeries and specialises in keyhole techniques for gastrointestinal cancers at HCG Manavata Cancer Centre.
The success rate for oesophageal cancer in India is approximately 15% to 20% for 5-year survival. This figure reflects the high number of advanced-stage diagnoses in the country. Early-stage detection significantly improves outcomes, as specialised centres offer surgical and robotic interventions.
Bookimed Expert Insight: Indian oncology excels in surgical volume, which is a major driver of success. Surgeons such as Dr Surender Dabas hold regional records for robotic thoracic procedures. High repetition allows surgical teams to manage complex food pipe reconstructions more precisely. This sets them apart from lower-volume centres. Patients should prioritise clinics with JCI or NABH accreditation for western-equivalent safety standards.
Patient Consensus: Patients find chemotherapy in India very affordable. They often note that immunotherapy such as Keytruda can lead to significant tumour shrinkage. This occurs even in advanced cases. Seeking a second opinion and MSI testing is frequently recommended. It helps determine the best treatment path.
India offers oesophageal cancer care at JCI-accredited centres like Apollo Indraprastha and BLK Super Speciality. These hospitals specialise in robotic oesophagectomy and precision radiotherapy. Specialist oncology teams provide comprehensive paths from PET-CT staging to complex minimally invasive surgery within 10–14 days.
Bookimed Expert Insight: Indian clinics like Global Hospital Mumbai report treatment costs 30% to 50% lower than Western countries. Large networks such as Manipal Hospitals serve 2,000,000 patients annually. This massive volume means specialists like Dr Raj Nagarkar have performed over 50,000 cancer surgeries. This level of repetition often leads to higher surgical precision in complex oesophageal resections.
Patient Consensus: Patients in India recommend starting nutritional planning early via feeding tubes to maintain strength during intensive treatment. Top corporate hospitals offer fast access. Still, seeking a second oncologist's opinion remains a common practical step.
Indian oncology centres offer multimodal oesophageal cancer treatments, including robotic oesophagectomy, targeted therapy, and radiation like Halcyon. Accredited facilities in Delhi, Mumbai, and Bengaluru provide global standard care. Specialists such as Dr Surender Dabas and Dr Raj Nagarkar have performed over 50,000 cancer surgeries. They use robotic systems to improve recovery outcomes.
Bookimed Expert Insight: While many Australian patients seek standard chemotherapy, India’s top centres like HCG Manavata and Global Hospital Chennai specialise in ultra-high-volume surgical oncology. Dr Raj Nagarkar and Dr Raja Sundaram have each performed over 15,000 to 50,000 surgeries. This specific expertise in complex thoracic resections often allows for minimally invasive approaches. These approaches can reduce hospital stays to just a few days.
Patient Consensus: Patients in India find that combining standard chemotherapy with immunotherapy significantly improves eating ability. Many note that robotic surgery and targeted therapies are accessible at major corporate hospitals, often with cost concession programs for advanced immunotherapy drugs.
Multidisciplinary teams (MDT) in India involve specialists collaborating to create tailored treatment plans for complex oesophageal cases. These teams integrate expertise from surgical, medical, and radiation oncologists. This standard care model ensures adherence to clinical pathways. It improves survival outcomes and patient quality of life.
Bookimed Expert Insight: Patient volume deeply influences MDT expertise in India. Major centres like Manipal Hospitals serve 2,000,000 patients annually across their network. Specialists at high-volume hubs, such as Dr Surender Dabas at BLK Super Speciality Hospital, have performed over 8,000 thoracic procedures. This massive caseload allows teams to refine protocols for rare or late-stage presentations that smaller clinics rarely see.
Patient Consensus: Patients note it is essential to request a team-confirmed diagnosis before starting treatment in India. Bringing all previous diagnostic reports helps streamline the consensus process and avoids unnecessary delays.
Indian hospitals provide specialised care for international oesophageal cancer patients. JCI-accredited centres offer robotic surgeries and precision therapies. These facilities provide support for visas and logistics. Experts such as Dr Raj Nagarkar have performed over 50,000 cancer surgeries.
Bookimed Expert Insight: Indian oncology centres handle massive patient volumes, with Manipal Hospitals alone serving 2,000,000 patients annually. This scale allows surgeons to specialise deeply. Dr Raj Nagarkar at HCG Manavata has conducted 50,000 surgeries. This high frequency often leads to better surgical precision in complex oesophageal resections.
Patient Consensus: Patients note that major Indian centres have long-standing infrastructure for international visitors. They often recommend sharing pathology results with senior oncologists for second opinions. Many suggest that even in advanced stages, these hospitals provide ongoing options like immunotherapy every four weeks.
Patients should plan for 4 to 8 weeks in India for oesophageal cancer surgery. This duration covers pre-surgical PET-CT scans and the procedure. It also includes 7 to 14 days of inpatient recovery. Multi-modal protocols involving chemotherapy or radiation can extend the total stay to 12 weeks.
Bookimed Expert Insight: Choice of facility significantly impacts the schedule. This is because major centres like Manipal Hospitals serve 2,000,000 patients annually. High-volume hospitals offer deep expertise. However, corporate facilities like Fortis Gurgaon often provide faster access to theatre. This avoids the 3-week equipment wait times sometimes found in crowded institutes.
Patient Consensus: Patients note that corporate hospitals streamline the 6-week chemo-radiation blocks before surgery. They recommend arranging comfortable local housing for after surgery. This helps manage dietary changes and cold sensitivity. Stay durations vary if immunotherapy like Keytruda is included. This could require multiple visits to India.